Amedisys Inc
NASDAQ:AMED
Amedisys Inc
NASDAQ:AMED
Price:
96.13 USD
1.8%
Market Closed
Updated:
May 21, 2024
Amedisys Inc
Depreciation & Amortization
|
Amedisys Inc
Depreciation & Amortization Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Depreciation & Amortization
-$17.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
6%
|
|
|
DaVita Inc
NYSE:DVA
|
Depreciation & Amortization
-$754.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Depreciation & Amortization
-$111m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Depreciation & Amortization
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-42%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Depreciation & Amortization
-$226.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-11%
|
See Also
What is Amedisys Inc's Depreciation & Amortization?
Depreciation & Amortization
-17.5m
USD
-17.5m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Depreciation & Amortization amounts to -17.5m USD.
What is Amedisys Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
6%
6%
Over the last year, the Depreciation & Amortization growth was 18%. The average annual Depreciation & Amortization growth rates for Amedisys Inc have been 17% over the past three years , -7% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
